Sign in
4/A

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-017418

Director sold 2,500 shares at $30.80 ($77,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PIMSTONE SIMON N. Director 2022-03-08 Sale −2,500 $30.80 $77,000 193,135 D: show line 1 in the form
Open-market sales · 2,500 sh · avg $30.80 · $77,000
Loading xslF345X03/doc4a.xml…